[Development and results of surgical treatment of pleomorphic adenoma of the parotid gland in 245 patients, 1974-1994].
OBJECTIVE
To describe the results of parotidectomy for pleomorphic adenoma of the parotid gland in 245 patients, 1974-1994.


METHODS
Descriptive.


METHODS
Academic Medical Hospital, Free University, Amsterdam, the Netherlands.


METHODS
Of all patients follow-up data were obtained by yearly physical diagnostic examination during 10 years, and by a questionnaire (1995) from the general practitioners involved.


RESULTS
In the period 1974-1994, 246 primary surgical parotid procedures were performed on 245 patients for pleomorphic adenoma. The surgical procedures included: 131 'partial' and 61 'complete' superficial parotidectomies, 30 partial superficial/ deep lobe parotidectomies, 8 total parotidectomies, and 16 'selective' deep lobe parotidectomies. Eleven patients received postoperative radiotherapy for different reasons. The median follow-up was 95 months. Fourteen patients died without recurrent tumour. Two patients (0.8%) developed a local recurrence, both after total parotidectomy for a deep lobe tumour. None of the patients experienced permanent facial nerve paresis or paralysis. The incidence of auriculotemporal sweating for partial superficial parotidectomy proved to be 6.9% (9/I31) as compared with 13.1% (8/61) for complete superficial parotidectomy. In the later years, in the majority of patients, the posterior branch of the greater auricular nerve was preserved.


CONCLUSIONS
In the hands of the experienced head and neck surgeon partial parotidectomy is an effective treatment for the great majority of pleomorphic adenomas: local recurrence is rare, while in general morbidity is minimal. Rarely there is a need for prolonged follow-up.
Leverstein
H
H
Academisch Ziekenhuis Vrije Universiteit, Amsterdam, Afd. Keel-, Neus- en Oorheelkunde.
van der Wal
J E
JE
Tiwari
R M
RM
van der Waal
I
I
Snow
G B
GB
D008949:Adenoma, Pleomorphic / Q000473:pathology / Q000601:surgery*; D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010306:Parotid Gland / Q000601:surgery; D010307:Parotid Neoplasms / Q000473:pathology / Q000601:surgery*; D011182:Postoperative Care; D011183:Postoperative Complications / Q000209:etiology; D011882:Radiotherapy, High-Energy; D013514:Surgical Procedures, Operative / Q000379:methods; D013547:Sweating, Gustatory / Q000209:etiology